Study of low count MBL in people over 40
Part of Blood & lymphatic, Brain & nervous system, Cancer, Heart & circulation, Immune system & allergy, Infections, Mental health clinical trials.
This study looks at a condition called low count monoclonal B-cell lymphocytosis (LC MBL), which is a small number of abnormal immune cells in the blood. It aims to understand the risks and health effects of this condition in people over 40.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You must not have been diagnosed with a lymphoproliferative disorder (a type of blood cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study looks at blood-related conditions that run in families, including people with the condition and their close relatives. It may help doctors better understand what drives these inherited blood disorders and how to manage them.
This study looks at blood cell changes that can affect the immune system. It aims to better understand how these changes relate to immune problems and related diseases, and what might matter for treatment decisions.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
Hear when a new Monoclonal B-Cell Lymphocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.